Finance

Beta
Lists
TECX:NASDAQ
Tectonic Therapeutic Inc
$31.99
+3.09%
(+0.96) 1D
$31.99
-0.00% (-0.00060)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TECX...
Open
$31.26
High
$32.11
Low
$30.22
Mkt. cap
603.63M
Avg. vol.
165.21K
Volume
307.18K
52-wk high
$36.03
52-wk low
$14.38
EPS
-$4.46
Beta
1.22
Shares outstanding
18.87M
No. of employees
60
Open
$31.26
High
$32.11
Low
$30.22
Mkt. cap
603.63M
Avg. vol.
165.21K
Volume
307.18K
52-wk high
$36.03
52-wk low
$14.38
EPS
-$4.46
Beta
1.22
Shares outstanding
18.87M
No. of employees
60
News stories
From sources across the web
About Tectonic Therapeutic Inc
CEO-
Employees60
Founded2019
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitetectonictx.com
Analyst ratings
Based on 9 analysts giving stock ratings to TECX in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for TECX in the last 3 months.
Highest
Current $31.99
$101.00 (+215.72%)
Average
$80.75 (+152.42%)
Lowest
$60.00 (+87.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Benjamin Burnett
Wells Fargo
Buy
Reiterated
$101.00
+215.7%
06/12/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
$85.00
+165.7%
06/10/2026
Gaurav Maini
LifeSci Capital
Buy
Reiterated
$88.00
+175.1%
06/10/2026
Martin Auster
Raymond James
Buy
Maintained
$81.00
+153.2%
05/26/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$76.00
+137.6%
05/18/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$80.00
+150.1%
05/15/2026
Danielle Brill
Truist Financial
Buy
Maintained
$60.00
+87.6%
05/11/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
$75.00
+134.4%
05/08/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.18M
16.93M
16.34M
20.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.15M
4.96M
5.18M
6.43M
Operating expense
22.33M
21.89M
21.52M
27.30M
Total operating expenses
22.33M
21.89M
21.52M
27.30M
Operating income
-22.33M
-21.89M
-21.52M
-27.30M
Other non operating income
-48.00K
-31.00K
-8.00K
-113.00K
EBT including unusual items
-19.01M
-19.04M
-18.97M
-25.24M
EBT excluding unusual items
-19.01M
-19.04M
-18.97M
-25.24M
Income tax expense
976.00K
-
254.00K
-
Effective tax rate
-5.13%
-
-1.34%
-
Other operating expenses
-
-
-
-
Net income
-19.98M
-19.04M
-19.23M
-25.24M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
3.39M
2.90M
2.56M
2.18M
Interest expense
-17.00K
-14.00K
-12.00K
-8.00K
Net interest expenses
3.37M
2.89M
2.55M
2.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.99M
-21.55M
-21.18M
-27.00M
Gain or loss from assets sale
60.00K
93.00K
-
23.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of TECX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer